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Abstract 
 Fibrodysplasia Ossificans Progressiva (FOP) is an autosomal dominant disease that 
affects one in every two million persons.  It is a disease that stimulates ossification in injured 
muscle cells.  This mutation affects the bone morphogenetic protein receptor (BMPR), which is 
found on the surface of skeletal muscle cells.  When bone morphogenetic proteins (BMP) come 
into contact with these receptors it causes a cascade of events to occur that transform skeletal 
muscle cells into bone cells.  This mutation causes these receptors to remain constitutively 
activated in the presence of BMP.  We compared the effects of human BMP2 on mouse myoblast 
cells (C2C12) and rhabdomyosarcoma (RD; human muscle cancer) cells.  RD cells were used as 
the human muscle model for the BMPR.  The results confirmed that C2C12 cells increased 
alkaline phosphatase (ALT) levels when BMP2 was added.  ALT is one of the precursors for 
bone growth.  The RD cells unexpected displayed relatively high ALT levels without the 
presence of BMP2.  These results demonstrate trans-differentiation in C2C12 and RD cells, 
confirming that myoblast cells were reprogrammed to osteoblast cells by the addition of BMP2.  
Trans-differentiation is being initiated by the inflammatory response and molecules that are 
being delivered to these injured muscle cells.  This experiment was preliminary work to find 
specific molecules that are coupling with BMP to transform injured myoblast cells into 
osteoblast cells.           
Introduction 
Fibrodysplasia Ossificans Progressiva (FOP) is an autosomal dominant disease caused by 
a sporadic mutation that produces erratic bone growth within muscle tissue [1].  Most patients 
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carry a single nucleotide change from guanine to adenosine on chromosome 2q23-24 [1].  FOP is 
not linked with gender or race and currently is estimated to affect one in every two million 
persons [2].  The onset of FOP can be triggered by minor injuries and even some viral infections, 
causing heterotrophic ossification (HO) [2].  However, FOP seems to impact only skeletal 
muscles and not cardiac or smooth muscles [2].  HO, in abnormal conditions, will cause non-
skeletal tissues to ossify and turn into bone [3].  In normal conditions, HO contributes to 
embryonic bone formation as well as bone regeneration [3].   
The FOP mutation lies on the bone morphogenetic protein (BMP) type-I receptor 
(BMPRIA) [4].  BMPs stimulate mesenchymal cells to differentiate into osteoblasts, therefore 
hindering muscle formation [4].  There are four different type-I BMP receptors, each of which 
has an affinity for a specific BMP isoform [4]. 
BMP signaling in a normal individual produces a heterodimeric complex of both type-I 
and type-II receptors, causing phosphorylation to occur at the glycine-serine (GS) domain [2].  
This triggers the type-I receptor to turn on cytoplasmic smad 1/5/8 and p38MAPK signaling [2].  
This activates inhibitors of differentiation which are proteins that can induce or inhibit cellular 
differentiation when they are overexpressed [5].  BMPRIA is critical in stopping BMP signaling 
by blocking the binding site with antagonists [5].  However, the FOP mutation is positioned on 
codon 206 in the GS domain, where BMPRIA is located [6].  Therefore, FOP individuals have a 
slightly activated, constitutive BMP type-I receptor [2].  Thus, downstream signaling is not 
controlled by the ligands and can generate unregulated bone and cartilage formation [2].        
In FOP patients, BMP4 signaling is impaired, which may account for HO and the 
characteristic malformation of the big toe [7].  In a normal individual, there are autoregulatory 
negative feedback loops for BMP4 [7].  When presented with BMP4, certain cells will secrete 
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antagonists such as Noggin, gremlin, chordin, and follistatin [7].  These antagonists will bind to 
the BMP4 ligands and inhibit BMP4 [7].  High BMP4 activity in FOP individuals indicates that 
there are dysregulated negative feedback loops that are not caused from malfunctioning BMP 
antagonists [7].         
One way to regulate intracellular signaling is through the use of smad proteins, which 
have the ability to stop myogensis, but some smad proteins will induce BMP signaling and cause 
HO [8].  One of the markers related to bone growth is elevated by the level of alkaline 
phosphatase (ALT) activity [8].  Smad 7 and dorsomorphin inhibit BMPRIA activity and 
suppress bone formation by decreasing ALT activity [8].    
Regulatory proteins such as Noggin and Sonic Hedgehog (SHH) are essential for muscle 
development, but myogenesis will not occur in the presence of BMPs [9].   The muscle 
precursors require Wnt signaling and the absence of BMPs in order to differentiate into 
myoblasts [10]. Different types of cellular signals are used in different regions of the body [11].  
If the cells are located near the neural tube or surface epithelium, they will be regulated by Wnt 
signaling and BMPs [11].   If the cells are located closer to the notochord, the signaling is 
controlled by SHH and Noggin [11].  
Wnt signaling is also important in osteoblast development because it causes a cascade of 
intracellular pathways in those cells [12].  Indian hedgehog (Ihh) proteins are present in early 
osteogenic progenitor cells that cause osteoblast differentiation, and these proteins are required 
for endochondral bone formation [12].  Endochondral ossification is the growth of bone tissue in 
cartilage [13].  Hedgehog-induced osteogenesis requires Wnt signaling, and Wnt7b is a crucial 
ligand for controlling osteogenesis [12].  Also, other precursors such as Tie2-Cre, which is an 
endothelial precursor, will contribute to osteogenic and chondrogenic stages [14].  
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 Osteoprogenitor cells in the periosteum are initiated when muscle is injured [15].  These 
cells are also found with bone marrow stem cells (BMSC) [16].  Muscles affect bone growth by 
secreting growth factors that will aid in signaling osteogenesis [15].  This is why bone fractures 
that damage less muscle will regenerate faster whereas fractures with severe muscle trauma will 
regenerate much slower [15].  Growth factors such as transforming growth factors (e.g. TGF-β1, 
TGF-β2), vascular endothelial growth factors, and basic growth factors help regenerate tissue 
and bone [17].  Platelet-rich plasma stimulates bone generation due to its abundant growth 
factors [18].  
Bone marrow stem cells (BMSC) are pluripotent and have the ability to transform into 
osteoblastic, chondrogenic, myogenic, and adopogenic lineages [16].  It was proposed that 
circulating BMSC aid in the development of bone [16].  Once osteoprogenitors express specific 
transcription factors such as Runx2, it was thought that the stem cell would follow an 
osteochondral lineage [16].  As this process continues, more distinct markers indicate bone 
differentiation [16].  One study found that muscle adjacent to bone that experienced trauma was 
able to trans-differentiate; the muscle cells and any non-osseous progenitors in the damaged 
region were reprogrammed to form bone [16].  Trans-differentiation is a process that occurs in 
injured myoblast cells.  It is initiated by the inflammatory response and the presence of 
unidentified molecules.  Identifying these molecules will inevitably lead to suppressing this 
transformation and helping FOP individuals.  My experiment is setting the ground work by 
examining mouse muscle (C2C12) cells and rhabdomyosarcoma (RD; human muscle cancer) 
cells.  This experiment is to test the presences of bone morphogenetic protein receptors on the 
muscle cells and their response to human BMP-2 stimulus.             
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Materials and Methods: 
A human skeletal muscle-origin cancer cell line of rabdomyocarcinoma cells (RD) and a 
mouse myoblast cell line, C2C12, were used for this experiment.  The C2C12 cell lines and RD 
cells lines were purchased from ATCC (Manassas, VA).  A tissue culture media, fetal bovine 
serum, laminar flow hood, and a CO₂ incubator were used to keep the cells alive.  Human BMP-
2 and p-nitrophenyl phosphate stain were purchased from Thermo Fisher Scientific (Waltham, 
MA).      
Setting up a welled plate with cover slides: 
Four pieces of 22mm glass cover slips were sterilized in 70% ethanol for fifteen minutes.  
Each sterile cover slip was placed into one well of a six-well plate.  The six-well plate took five 
minutes to air dry without the lid in the laminar flow hood.  All of the slides in the wells were 
dry and all major drops of ethanol had evaporated before media and cells were added.   
C2C12 and BMP: 
The mouse muscle C2C12 cells were grown first.  When the cells filled 90% of the flask 
the experiment could begin because enough cells were present.  The growth media was removed 
from the flask and 1mL of .25% Trypsin was added.  Trypsin is a protein that digests the 
extracellular matrix (ECM) of the cells causing them to detach from the flask. After trypsin was 
added, the flask was placed into an incubator at 37°C for two minutes to speed up the process.  
By using a microscope one could then see if the cells were suspended, and if not, the flask was 
tapped vigorously on its side.  The cells needed to be freely suspended in order to distribute them 
into wells at the correct concentrations.  Once the cells were all suspended, 5mL of regular 
medium (EMEM) was added and mixed.  This makes the cells disassociate with each other for 
dispersal.  The EMEM contains Ca²+ which is a molecule that binds to trypsin, allowing the cells 
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to attach themselves to the surface of the flask again, so the next couple of steps need to be done 
before that occurs.  Ten microliters of cells were and placed on a haemocytometer to count the 
number of cells present in 1ml of solution.  After counting the cells in each of the four chambers 
of the grid, an average was calculated to estimate the number of cells per milliliter.  A volume of 
180µL of cells in solution was placed on top of the cover slips in each of the four wells.  Then 
one milliliters of fresh EMEM medium was added to each of the wells.  The cells were then 
placed into the incubator.  After two days, 20µL of human BMP-2 were added to two of the four 
wells and the plates were placed back into a CO2 incubator for another seven days.   
Fixing, staining, and mounting cells: 
After the seven days, the six-welled plate was removed from the incubator and the media 
was removed from all the wells that were going to be fixed.  One milliliter of 4% formalin 
(5.4mL of 37% formalin in 44.6mL of nonsterile PBS) was added to the wells and the cells were 
incubated at room temperature for fifteen minutes.  Next, all of the 4% formalin was removed 
from the wells and 1mL of TBS (8g 1.37M NaCl, 0.2g of 0.027M KCl, 3g of 0.25M Tris/HCl, 
and 100mL of DI) was added.  The cells were placed in TBS for ten minutes before staining 
them.  
The stain used is an enzyme that detects alkaline phosphatase (ALK) activity [16].  When 
this enzyme comes into contact with ALK, it causes a color change to occur and stains the cells 
blue.  The TBS was removed from all the wells that were being stained and had already been 
fixed.  Then 1ml of stain was added to those wells.  The plate was then placed into the CO2 
incubator at 37°C for 30 minutes.  After 30 minutes, the stain was removed and 1mL of TBS was 
added.  The stained cover slips were then ready to be mounted to slides.        
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 The cover slips inside the wells were removed and placed on a paper towel, cell side 
facing upward, by using tweezers.  The paper towel was labeled clearly to identify which cover 
slips they were.  The cover slips were left to dry and two clean slides were used.  The cover slips 
were mounted two per slide; one was a control and the other with a treatment.  Both cover slips 
were mounted using mounting media and the slides were labeled accordingly.   
RD and C2C12 experiment:  
 For this experiment, four wells each of two six-welled plates were used.  Cover slips 
were prepared in the eight wells.  RD and C2C12 cells were counted using a haemocytometer.  
Both flasks of RD and C2C12 cells were trypsinized and each of four wells on one plate received 
180µL of C2C12.  The remaining four wells on a different plate each received 220µL of RD 
cells.  Both plates were labeled with cell type and treatment. Then 1mL of EMEM was added 
into each of the wells and left in the CO2 incubator at 37°C for two days.  Then 20µL of BMP 
were added to two RD wells and two C2C12 wells.  The plates were then placed back into the 
incubator for seven days.  The cells were then fixed, stained, and mounted onto slides.       
RD media and RD cell experiment: 
 Two 6-welled plates were set up as previous described and cover slips were added to a 
total of eight wells.  Only C2C12 cells were used in the wells first.  The C2C12 cells were 
counted using a haemocytometer and 220µL of cells were added to each of the wells.  The plates 
were then placed back into the CO2 incubator at 37°C for two days.  Next, 20µL of BMP were 
added to two of the wells.  The two wells without BMP had their media removed and replaced 
with 1mL of RD-condition medium.  Media was removed from another two wells (without BMP 
and without RD condition medium) and replaced with 1mL of RD cells.  The RD cells were 
trypsinized and then diluted with 5mL of fresh EMEM media before being added to the wells.  
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The two remaining wells were used as controls and only were C2C12 cells and EMEM.  The 
plates were placed in the incubator for seven days after which time the cells were fixed and 
stained.  All of the wells were mounted except for one RD cell and one RD-condition medium 
cover slide.   
Cartilage Stain: 
 The two wells that were not mounted (one RD-condition medium and one RD cell) were 
used to see if cartilage formation had occurred.  It appeared that cells on both these cover slips 
were forming aggregates and looked similar to cartilage.  The control was the C2C12 cells that 
were not treated with RD-condition medium or RD cells.  Alcian green cartilage stain was used 
to detected cartilage by staining the cartilage green.  All of the TBS was removed from both 
wells and 1mL of the stain was added.  After thirty minutes, it was placed into the refrigerator for 
one day.  Then both cover slips were mounted after looking at them under a dissecting 
microscope.    
 
Results 
 As expected, when the C2C12 cells were introduced to BMP, they released alkaline 
phosphate, which was made apparent with staining (figure 1).  The control cells (the C2C12 cells 
that did not have BMP added) stained very lightly (figure 1).  The RD cells with BMP stained 
roughly fifty percent as well as the RD cells without BMP (figure 2).  The RD cells were added 
to the C2C12 cells and exhibited ALT activity after staining (figure 3).  The C2C12 cells with 
the addition of RD-condition media clumped together forming an aggregation of cells that 
stained darkly with ALT activity (figure 3).  The RD –condition media was stained with Alcian 
Green and some of the aggregates stained green but it was inconclusive (figure 4).  Also, the RD 
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media with the C2C12 cells showed more connections between the cells (figure 4).  The control 
with C2C12 cells exhibited no cartilage staining.   
Discussion: 
Mouse muscle (C2C12) cells reacted as expected when introduced to human BMP-2; the 
cells exhibited large amounts of alkaline phosphatase activity.  When the muscle cells were 
subjected to BMP-2, their formation changed.  The C2C12 cells began to form clusters and the 
alkaline phosphatase activity appeared to form webs between the cells.  The BMP-2 successfully 
caused trans-differentiation to occur in the C2C12 cells.       
 The human tumor (RD) cells have the same BMPR as the C2C12 cells.  We expected the 
same results with the RD cells as with the mouse muscle cells, but surprisingly when the RD 
cells were subjected to BMP-2 the outcome was different.  It appeared that the RD cells stained 
for alkaline phosphatase activity with and without the addition of BMP-2.   Close to 80% of the 
C2C12 cells had improved alkaline phosphatase activity with BMP-2.   It is possible that when 
the RD cells were harvested, some bone stem cells were accidentally collected.  This would 
cause contamination of the sample by mixing the two types of cells.  It is also possible that RD 
cells might have the ability to switch between lineages more easily because the tumor caused 
some genes to be turned on while other genes had been silenced.  Another theory is that the RD 
cell is a type of stem cell that did not differentiated properly.  This allows it to have the ability to 
become both muscle or bone cells.  
 These results promoted us to test whether the RD cells were secreting a molecule or 
producing a molecule within the cells.  These molecules are causing increased levels of ALT 
which signify the initiation of trans-differentiation.  The RD-condition media when added to the 
C2C12 cells caused the cells to aggregate. These cells appeared to be in the beginning stages of 
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differentiation.  To further understand this reaction we stained the cells for cartilage, however the 
results were inconclusive. If cartilage was presence, it would have indicated that cartilage is 
formed first instead of direct bone growth.  This process is called endochondral ossification.   
The C2C12 cells and RD cells had BMPR.  The RD cells unexpectedly expressed 
increased levels of ALT without the addition of BMP-2.  RD cells are therefore a bad human 
muscle model to use for future experiments.  The next couple of experiments need to focus on 
identifying molecules that are coupling with the inflammatory response and the trans-
differentiation process.  The results will reveal new information about FOP signaling and help to 
discover a treatment that can suppress heterotrophic ossifications in FOP patients.   
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Figure 1:  
 
Figure 1: Mouse muscle cells (C2C12). A: control cells that were not given BMP-2.  B: cells 
treated with BMP-2. C: higher magnification of the cells that were treated with BMP-2.  
Alkaline phosphate activity is revealed by the blue stain.    
A 
B 
C 
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Figure 2: 
 
 
 
 
 
 
 
 
 
Figure 2: Mouse muscle cells (C2C12) cells and human tumor muscle (RD cells treated with or 
without BMP-2.  A: C2C12 cells that were not treated with BMP-2. B: C2C12 cells treated with 
BMP-2.  C: control RD cells D: RD cells subjected to BMP-2.  Alkaline phosphate activity stains 
blue.    
 
 
A B 
C D 
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Figure 3: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: C2C12 cells treated with RD cells or RD media A, B, and C: C2C12 cells treated with 
RD cells. D, E and F: C2C12 cells treated with RD media; note the clumping cells. Blue staining 
indicates alkaline phosphate activity.   
 
A D 
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Figure 4: 
 
 
 
 
 
 
 
Figure 4: C2C12 cells treated with and without RD media. A and B: control C2C12 cells. C and 
D: C2C12 cells treated with RD media.  Alkaline phosphate activity stains blue.  The cartilage 
stain (green) indicates trans-differentiation in the presence of RD media.   
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